Artelo Biosciences Reports Second Quarter Fiscal Year 2020 Financial Results and Provides Business Update

LA JOLLA, Calif., April 14, 2020 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate the endocannabinoid system and related biological signaling pathways, today reported financial and operating results for the second quarter of its fiscal year ended February 29, 2020.